2021
DOI: 10.1016/j.bspc.2021.103059
|View full text |Cite
|
Sign up to set email alerts
|

Continuous glucose monitoring to measure metabolic impact and recovery in sub-elite endurance athletes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 53 publications
0
15
0
Order By: Relevance
“…Another case study of an Ultraman triathlete with T1D also showed postexercise hyperglycaemia, along with significant increases in creatine kinase, C‐reactive protein, and aldosterone levels, which could help to explain the apparent increase in insulin resistance postevent 8 . Other studies have shown glycaemic and insulin dose variability in endurance athletes with T1D who are not using AID systems, thereby suggesting that some forms of endurance exercise may promote some level of whole‐body insulin resistance 3,4,18,19 . Notably, in the 1 week following the ride, the study participant spent considerably less percentage TIR (49.6% ± 17.0%), with a markedly elevated percentage TAR2 (19.4% ± 10.3%), compared with the preride (2.0% ± 4.1%) and in‐ride (12.6% ± 9.1%) periods.…”
Section: Discussionmentioning
confidence: 85%
See 3 more Smart Citations
“…Another case study of an Ultraman triathlete with T1D also showed postexercise hyperglycaemia, along with significant increases in creatine kinase, C‐reactive protein, and aldosterone levels, which could help to explain the apparent increase in insulin resistance postevent 8 . Other studies have shown glycaemic and insulin dose variability in endurance athletes with T1D who are not using AID systems, thereby suggesting that some forms of endurance exercise may promote some level of whole‐body insulin resistance 3,4,18,19 . Notably, in the 1 week following the ride, the study participant spent considerably less percentage TIR (49.6% ± 17.0%), with a markedly elevated percentage TAR2 (19.4% ± 10.3%), compared with the preride (2.0% ± 4.1%) and in‐ride (12.6% ± 9.1%) periods.…”
Section: Discussionmentioning
confidence: 85%
“…8 Other studies have shown glycaemic and insulin dose variability in endurance athletes with T1D who are not using AID systems, thereby suggesting that some forms of endurance exercise may promote some level of whole-body insulin resistance. 3,4,18,19 Notably, in the 1 week following the ride, the study participant spent considerably less percentage TIR (49.6% ± 17.0%), with a markedly elevated percentage TAR2 (19.4% ± 10.3%), compared with the preride (2.0% ± 4.1%) and in-ride (12.6% ± 9.1%) periods. Bolus, basal, and total daily insulin were also elevated throughout this 7-day recovery time, suggesting that the athlete may have been in a comparatively insulin-resistant state.…”
Section: Discussionmentioning
confidence: 87%
See 2 more Smart Citations
“…CGM systems can be used to monitor the effects of intense physical exertion on glucose concentration in the recovery period. In a study with 10 athletes, both glucose dynamics after carbohydrate intake and overnight basal glucose values were altered following intense exercise to exhaustion [83]. CGM data can be used to determine when the glucose profile is normalized and returns to the pre-exercise profile.…”
Section: Cgm For Optimization Of Athletic Performancementioning
confidence: 99%